These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6591851)

  • 21. Teicoplanin, its pharmacokinetics, blister and peritoneal fluid penetration.
    Wise R; Donovan IA; McNulty CA; Waldron R; Andrews JM
    J Hosp Infect; 1986 Mar; 7 Suppl A():47-55. PubMed ID: 2871097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacokinetics and tissue penetration of teicoplanin.
    McNulty CA; Garden GM; Wise R; Andrews JM
    J Antimicrob Chemother; 1985 Dec; 16(6):743-9. PubMed ID: 2936707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penetration of enoxacin into bronchial secretions.
    Fong IW; Vandenbroucke A; Simbul M
    Antimicrob Agents Chemother; 1987 May; 31(5):748-51. PubMed ID: 3475036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of experimental Pseudomonas corneal ulcers with enoxacin, a quinolone antibiotic.
    Sugar A; Cohen MA; Bien PA; Griffin TJ; Heifetz CL; Mehta S
    Arch Ophthalmol; 1986 Aug; 104(8):1230-2. PubMed ID: 3461752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteers.
    O'Neill P; Nye K; Douce G; Andrews J; Wise R
    Antimicrob Agents Chemother; 1990 Feb; 34(2):232-4. PubMed ID: 2327771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone penetration of enoxacin in patients with and without osteomyelitis.
    Fong IW; Rittenhouse BR; Simbul M; Vandenbroucke AC
    Antimicrob Agents Chemother; 1988 Jun; 32(6):834-7. PubMed ID: 3166359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and suction blister fluid penetration of a semisynthetic injectable streptogramin RP 59500 (RP 57669/ RP 54476).
    Bernard E; Bensoussan M; Bensoussan F; Etienne S; Cazenave I; Carsenti-Etesse E; Le Roux Y; Montay G; Dellamonica P
    Eur J Clin Microbiol Infect Dis; 1994 Sep; 13(9):768-71. PubMed ID: 7843184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and metabolism of single oral doses of trovafloxacin.
    Vincent J; Teng R; Dalvie DK; Friedman HL
    Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacin.
    Child J; Andrews JM; Wise R
    Antimicrob Agents Chemother; 1995 Feb; 39(2):513-5. PubMed ID: 7726523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin.
    Nix DE; Schultz RW; Frost RW; Sedman AJ; Thomas DJ; Kinkel AW; Schentag JJ
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():87-95. PubMed ID: 3162906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.
    Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():67-77. PubMed ID: 3162904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam.
    McNulty CA; Garden GM; Ashby J; Wise R
    Antimicrob Agents Chemother; 1985 Sep; 28(3):425-7. PubMed ID: 4073864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and pharmacokinetic studies on enoxacin in ear, nose and throat infections.
    Federspil PJ; Lind A; Tiesler E; Schmidt B
    Infection; 1986; 14 Suppl 3():S211-2. PubMed ID: 3463545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and tissue penetration of temocillin.
    Lockley MR; Brown RM; Wise R
    Drugs; 1985; 29 Suppl 5():106-8. PubMed ID: 4029011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days.
    Dobbs BR; Gazeley LR; Stewart IA; Edwards IR
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():61-6. PubMed ID: 3162903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penetration of enoxacin into human bronchial mucosa.
    Marlin GE; Braude PD; Whelan AJ; Somogyi AA
    Am Rev Respir Dis; 1986 Dec; 134(6):1209-12. PubMed ID: 3466562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin.
    Cooper MA; Nye K; Andrews JM; Wise R
    J Antimicrob Chemother; 1990 Oct; 26(4):533-8. PubMed ID: 2174853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and tissue penetration of azthreonam.
    Wise R; Dyas A; Hegarty A; Andrews JM
    Antimicrob Agents Chemother; 1982 Dec; 22(6):969-71. PubMed ID: 6891575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers.
    Melnik G; Schwesinger WH; Teng R; Dogolo LC; Vincent J
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):424-6. PubMed ID: 9758286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and tissue penetration of cefpirome, a new cephalosporin.
    Kavi J; Andrews JM; Ashby JP; Hillman G; Wise R
    J Antimicrob Chemother; 1988 Dec; 22(6):911-6. PubMed ID: 3243739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.